Siciliano, Massimo
 Distribuzione geografica
Continente #
EU - Europa 2.070
NA - Nord America 1.904
AS - Asia 503
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
OC - Oceania 3
Totale 4.507
Nazione #
US - Stati Uniti d'America 1.896
DE - Germania 923
SE - Svezia 400
CN - Cina 278
UA - Ucraina 203
IT - Italia 159
SG - Singapore 101
IE - Irlanda 100
FR - Francia 80
GB - Regno Unito 73
FI - Finlandia 59
TR - Turchia 39
IN - India 38
RU - Federazione Russa 32
IR - Iran 21
BE - Belgio 18
HK - Hong Kong 15
CI - Costa d'Avorio 12
EU - Europa 8
CA - Canada 7
GR - Grecia 5
BR - Brasile 4
JP - Giappone 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
RO - Romania 3
CZ - Repubblica Ceca 2
MK - Macedonia 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
KW - Kuwait 1
MU - Mauritius 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.507
Città #
Chandler 469
Ashburn 132
Jacksonville 120
San Mateo 104
Dublin 99
Ann Arbor 74
Singapore 69
Nürnberg 62
New York 58
Wilmington 58
Cattolica 57
Nanjing 57
Boston 46
Dearborn 46
Woodbridge 39
Izmir 38
Marseille 32
Princeton 32
Redwood City 31
Beijing 27
Bremen 26
Nanchang 26
Moscow 24
Zhengzhou 24
Helsinki 23
Lawrence 23
Houston 20
Hangzhou 19
Lancaster 19
Leawood 19
Munich 19
Andover 18
Augusta 18
Brussels 18
Hebei 17
Tianjin 17
Seattle 16
Shenyang 15
Boardman 13
Fairfield 13
Rome 13
Abidjan 12
Falls Church 12
Changsha 11
Kunming 11
Los Angeles 11
Norwalk 10
University Park 10
Milan 9
Hong Kong 8
Kish 8
Bologna 7
Jiaxing 7
Mountain View 7
Shanghai 7
Detroit 6
Mcallen 6
Ardabil 5
Cambridge 5
Jinan 5
San Diego 5
Athens 4
Guangzhou 4
Hounslow 4
Las Vegas 4
London 4
Zanjan 4
Chicago 3
Costa Mesa 3
Fremont 3
Ningbo 3
Phoenix 3
Pune 3
Sacramento 3
San Jose 3
Toronto 3
Albuquerque 2
Bioggio 2
Busto Arsizio 2
Changchun 2
Grumo Nevano 2
Harbin 2
Hefei 2
Köln 2
Montréal 2
Nagold 2
Nardò 2
Portland 2
Redmond 2
San Francisco 2
Santa Clara 2
Skopje 2
São Paulo 2
Tokyo 2
Torino 2
Trento 2
Verona 2
Washington 2
Aachen 1
Acton 1
Totale 2.309
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 216
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 178
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 155
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 146
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 141
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 137
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 121
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 113
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 107
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 101
Model for end-stage liver disease dynamic stratification of survival benefit 97
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 97
Microscopic colitis 96
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 95
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 95
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 92
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 90
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 90
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 88
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 88
Liver transplantation in patients with alcoholic liver disease: A retrospective study 88
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 84
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 81
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 79
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 76
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 76
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 75
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 73
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 72
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 71
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 68
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 68
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 68
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 66
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 63
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 61
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 60
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 60
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 59
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 59
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 57
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 57
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 56
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 56
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 54
Regorafenib: a promising treatment for hepatocellular carcinoma 53
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 53
The new era of hepatitis C treatment: still the tip of the iceberg? 52
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 52
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 48
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 47
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 41
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 40
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 38
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 35
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 34
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 31
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 24
Totale 4.578
Categoria #
all - tutte 17.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020530 0 0 36 14 65 60 81 26 63 56 76 53
2020/2021476 30 43 7 44 58 29 48 11 58 33 99 16
2021/2022598 37 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/202568 16 34 18 0 0 0 0 0 0 0 0 0
Totale 4.578